In vivo optical imaging of acute cell death using a near-infrared fluorescent zinc-dipicolylamine probe

Molecular Pharmaceutics

Volumn 8, Issue 2, 2011, Pages 583-590

  Smith, Bryan A ^a   Gammon, Seth T ^b   Xiao, Shuzhang ^a   Wang, Wei ^c   Chapman, Sarah ^a   McDermott, Ryan ^c   Suckow, Mark A ^a   Johnson, James R ^b   Piwnica Worms, David ^b   Gokel, George W ^c   Smith, Bradley D ^a   Leevy, W Matthew ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSOURI ST LOUIS   (United States)

Author keywords

annexin V; cell death; in vivo imaging; ketamine; near infrared probe; zinc dipicolylamine

Indexed keywords

ALCOHOL; CYTOTOXIN; DIPICOLYLAMINE; FLUORESCENT DYE; KETAMINE; LIPOCORTIN 5; UNCLASSIFIED DRUG; ZINC;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; CELL DEATH; MOUSE; MUSCLE INJURY; MYOPATHY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DEATH; FLUORESCENT DYES; INFRARED RAYS; MICE; MICE, NUDE; MOLECULAR IMAGING; MUSCLE, SKELETAL; ORGANOMETALLIC COMPOUNDS; PICOLINES; SPECTROSCOPY, NEAR-INFRARED; ZINC;

EID: 79953807412     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100395u     Document Type: Article

References (63)

1. Broughton, B. R.; Reutens, D. C.; Sobey, C. G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40, e331-339.
2. Mahli, H.; Gores, G. J. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008, 134, 1641-1654.
3. Dalakas, M. C. Toxic and drug-induced myopathies. J. Neurol. Neurosurg. Psychiatry 2009, 80, 832-838.
4. Tashiykov, V.; Katz, Y.; Volkov, A.; Gazit, V.; Schreiber, S.; Zohar, O.; Pick, C. G. Minimal traumatic brain injury induce apoptotic cell death in mice. J. Mol. Neurosci. 2009, 37, 16-24.
5. Whelan, R. S.; Kaplinskiy, V.; Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 2010, 72, 19-44.
6. (a) Bader, M. Rat models of cardiovascular diseases. Methods Mol. Biol. 2010, 597, 403-414.
7. (b) Watchko, J. F.; Day, T. L. O.; Hoffman, E. P. Functional characteristics of dystrophic skeletal muscle: insights from animal models. J. Appl. Physiol. 2002, 93, 407-417.
8. (c) Olah, L.; Wecker, S.; Hoehn, M. Secondary deterioration of apparent diffusion coefficient after 1-h transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2000, 20, 1474-82.
9. Kartachova, M. D.; Verheij, M.; Hoefnagel, C. A.; van Eck, B. L.; Olmos, R. A. Methodological aspects and applications of in vivo imaging of apoptosis in oncology: an illustrative review. Curr. Med. Imaging Rev. 2005, 1, 221-228.
10. Van Engeland, M.; Nieland, L. J. W.; Ramaekers, F. C. S.; Schutte, B.; Reutelingsperger, C. Annexin V-affinity assay: a review of an apoptosis detection system based on PS exposure. Cytometry 1998, 31, 1-9. (Pubitemid 28050057)
11. Leading references include: (a) Blankenberg, F. G. In vivo imaging of apoptosis. Cancer Biol. Ther. 2008, 7, 1-8.
12. (b) Cohen, A.; Shirvan, A.; Levin, G.; Grimberg, H.; Reshef, A.; Ziv, I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 2009, 19, 625-637.
13. (c) De Saint-Hubert, M.; Prinsen, K.; Mortelmans, L.; Verbruggen, A.; Mottaghy, F. M. Molecular imaging of cell death. Methods 2009, 48, 178-187.
14. 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J. Nucl. Med. 2008, 49, 1345-1352.
15. (e) Shynkar, V. V.; Klymchenko, A. S.; Kunzelmann, C.; Duportail, G.; Muller, C. D.; Demchenko, A. P.; Freyssinet, J. M.; Mely, Y. Fluorescent biomembrane probe for ratiometric detection of apoptosis. J. Am. Chem. Soc. 2007, 129, 2187-2193.
16. (f) Kettunen, M. I.; Brindle, K. M. Apoptosis detection using magnetic resonance imaging and spectroscopy. Prog. Nucl. Magn. Reson. Spectrosc. 2005, 47, 175-187.
17. (a) Barnett, E. M.; Zhang, X.; Maxwell, D.; Chang, Q.; Piwnica- Worms, D. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 9391-9396.
18. (b) Edgington, L. E.; Berger, A. B.; Blum, G.; Albrow, V. E.; Paulick, M. G.; Lineberry, N.; Bogyo, M. Noninvasive optical imaging of apoptosis by caspase-targeted activity based probes. Nat. Med. 2009, 15, 967-973.
19. Gammon, S. T.; Villalobos, V. M.; Prior, J. L.; Sharma, V.; Piwnica-Worms, D. Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. Bioconjugate Chem. 2003, 14, 368-76.
20. Trabulo, S.; Cardoso, A. L.; Mano, M.; Pedroso de Lima, M. C. Cell-penetrating peptides-Mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 2010, 3, 961-993.
21. (a) Dillon, S. R.; Constantinescu, A.; Schissel, M. S. Annexin V binds to positively selected B cells. J. Immunol. 2001, 166, 58-71.
22. (b) Elliot, J. I.; Surprenant, A.; Marelli-Berg, F. M.; Cooper, J. C.; Cassady- Cain, R. L.; Wooding, C.; Linton, K.; Alexander, D. R.; Higgins, C. F. Membrane phosphatidylserine distribution as a non-apoptotic signaling mechanism in lymphocytes. Nat. Cell Biol. 2005, 8, 808-816.
23. Fadeel, B.; Xue, D. The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease. Crit. Rev. Biochem. Mol. Biol. 2009, 44, 264-277.
24. (a) Okada, H.; Mak, T. W. Pathways of apoptotic and nonapoptotic death in tumor cells. Nat. Rev. Cancer 2004, 4, 592-603.
25. (b) Marx, J. Autophagy: is it cancer's friend or foe? Science 2006, 312, 1160-1161.
26. (c) Degeterev, A.; Yuan, J. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 2008, 9, 378-390.
27. Appelt, U.; Sheriff, A.; Gaipl, U. S.; Kalden, J. R.; Voll, R. E.; Herrmann, M. Viable, apoptotic, and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand annexin V to dying but not viable cells and implication for PS-dependent clearance. Cell Death Differ. 2005, 12, 194-196.
28. Boersma, H. H.; Kietselaer, B. L.; Stolk, L. M.; Bennaghmouch, A.; Hofstra, L.; Narula, J.; Heidendal, G. A.; Reutelingsperger, C. Past, present, and future of Annexin A5: From protein discovery to clinical applications. J. Nucl. Med. 2005, 46, 2035-2050.
29. (a) Smith, G.; Nguyen, Q.-D.; Aboagye, E. O. Translational imaging of apoptosis. Anti-Cancer Agent Med. Chem. 2009, 9, 958-967.
30. (b) Zhao, M. In vivo apoptosis imaging agents and strategies. Anti- Cancer Agent Med. Chem. 2009, 9, 1018-1023.
31. (c) Faust, A.; Herman, S.; Wagner, S.; Haufe, G.; Schober, O.; Schäfers, M.; Kopka, K. Molecular imaging of apoptosis in vivo with scintigraphic and optical biomarkersa status report. Anti-Cancer Agent Med. Chem. 2009, 9, 968-985.
32. (a) Vanderheyden, J. L.; Liu, G. Z.; He, J.; Patel, B.; Tait, J. F.; Hnatowich, D. J. Evaluation of Tc-99m-MAG(3)-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Nuc. Med. Biol. 2006, 33, 135-144.
33. (b) Li, X.; Link, J. M.; Stekhova, S.; Yagle, K. J.; Smith, C.; Krohn, K. A.; Tait, J. F. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjugate Chem. 2008, 19, 1684-1688.
34. (a) Ke, S.; Wen, X. X.; Wu, Q. P.; Wallace, S.; Charnsangavej, C.; Stachowiak, A. M.; Stephens, C. L.; Abbruzzese, J. L.; Podoloff,D. A.; Li, C. Imaging taxane-inducing tumor apoptosis using PEGylated, In- 111-labeled annexin V. J. Nucl. Med. 2004, 45, 108-115.
35. Frey, B.; Schildkopf, P.; Rödel, F.; Weiss, E.-M.; Munoz, L. E.; Herrmann, M.; Fietkau1, R.; Gaipl, U. S. AnnexinA5 renders dead tumor cells immunogenic-implications for multimodal cancer therapies. J. Immunotoxicol. 2009, 6, 209-216.
36. Lambert, T. N.; Smith, B. D. Synthetic receptors for phospholipid headgroups. Coord. Chem. Rev. 2003, 240, 129-141.
37. (d) Alam, I. S.; Neves, A. A.; Whitney, T. H.; Boren, J.; Brindle, K. M. Comparison of the C2A domain of synaptotagmin-I and annexin- V as probes for detecting cell death. Bioconjugate Chem. 2010, 21, 884-891.
38. (a) Laumonier, C.; Segers, J.; Laurent, S.; Michel, A.; Coppée, F.; Belayew, A.; Vander Elst, L.; Muller, R. N. A new peptidic vector for molecular imaging of apoptosis identified by phage display technology. J. Biomol. Screen. 2006, 11, 537-545.
39. (b) Burtea, C.; Laurent, S.; Lancelot, E.; Ballet, S.; Murariu, O.; Port, M.; Vander Elst, L.; Corot, C.; Muller, R. N. Peptide targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques. Mol. Pharmaceutics 2009, 6, 1903-1919.
40. (c) Shao, R.; Xiong, C.; Wen, W.; Gelovani, J. G.; Li, C. Targeting phosphatidylserine on apoptotic cells with phages and peptides selected from a bacteriophage display library. Mol. Imaging 2007, 6, 417-416.
41. (d) Thapa, N.; Kim, S.; So, I.; Lee, B. H.; Kwon, I. C.; Choi, K.; Kim, I. S. Discovery of a phosphatidyserine-recognizing peptide and its utility in molecular imaging of tumour apoptosis. J. Cell. Mol. Med. 2008, 12, 1649-1660.
42. O'Neil, E. J.; Smith, B. D. Anion recognition using dimetallic coordination complexes. Coord. Chem. Rev. 2006, 250, 3068-3080.
43. Hanshaw, R. G.; Lakshmi, C.; Lambert, T. N.; Smith, B. D. Fluorescent detection of apoptotic cells using a family of zinc coordination complexes with a selective affinity for membrane surfaces that are enriched with phosphatidylserine. ChemBioChem 2005, 12, 2214-2220.
44. Adams, K. E.; Ke, S.; Kwon, S.; Liang., F.; Fan, Z.; Lu, Y.; Hirschi, K.; Mawad, M. E.; Barry, M. A.; Sevick-Muraca, E. M. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J. Biomed. Opt. 2007, 12, 024017.
45. Probe 2 is commercially available from Molecular Targeting Technologies, Inc. under the name PSVue-794.
46. Smith, B. A.; Akers, W. J.; Leevy, W. M.; Lampkins, A. J.; Xiao, S.; Wolter, W.; Suckow, M. A.; Achilefu, S.; Smith, B. D. Optical imaging of mammary and prostate tumors using a near infrared zinc(II)- dipicolylamine probe for anionic cell surfaces. J. Am. Chem. Soc. 2010, 132, 67-69.
47. Annexin Vivo 750 is commercially available from VisEn Medical.
48. Gokel, G. W.; Daschbach, M. M. Coordination and transport of alkali metal cations through phospholipid bilayer membranes by hydraphile channels. Coord. Chem. Rev. 2008, 252, 886-902.
49. Leevy, W. M.; Weber, M. E.; Schlesinger, P. H.; Gokel, G. W. NMR and ion selective electrode studies of hydraphile channels correlate with biological activity in E. coli and B. subtilis. Chem. Commun. 2005, 1, 89-91.
50. Leevy, W. M.; Gammon, S. T.; Levchenko, T.; Daranciang, D. D.; Murillo, O.; Torchilin, V.; Piwnica-Worms, D.; Huettner, J. E.; Gokel, G. W. Structure-activity relationships, kinetics, selectivity, and mechanistic studies of synthetic hydraphile channels in bacterial and mammalian cells. Org. Biomol. Chem. 2005, 3, 3544-3550.
51. Murillo, O.; Suzuki, I.; Abel, E.; Murray, C. L.; Meadows, E. S.; Jin, T.; Gokel, G. W. Synthetic transmembrane channels: functional characterization using solubility calculations, transport studies, and substituent effects. J. Am. Chem. Soc. 1997, 119, 5540-5549.
52. Koda, M.; Murawaki, Y.; Mitsuda, A.; Ohyama, K.; Horie, Y.; Suou, T.; Kawasaki, H.; Ikawa, S. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 2000, 88, 529-537. (Pubitemid 30056925)
53. Van de Putte, M.; Wang, H.; Chen, F.; de Witte, P. A.; Ni, Y. Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model. Acad. Radiol. 2008, 15, 107-113.
54. 68Ga Labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography. Bioorg. Med. Chem. 2010, 18, 5274-5281.
55. Davy, C. W.; Trennery, P. N.; Edmunds, J. G.; Altman, J. F.; Eichler, D. A. Local myotoxicity of ketamine hydrochloride in the marmoset. Lab Anim. 1987, 21, 60-67.
56. 18F-Annexin V. Toxicol. Sci. 2009, 111, 355-361.
57. Note: N = 3 mice were used for the ethanol cohort injected with probe 2.
58. Tait, J. F.; Gibson, D. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch. Biochem. Biophys. 1992, 298, 187-191.
59. (a) Ravassa, S.; Bennaghmouch, A.; Kenis, H.; Lindhout, T.; Hackeng, T.; Narula, J.; Hofstra, L.; Reutelingsperger, C. Annexin A5 down-regulates surface expression of tissue factor: a novel mechanism of regulating the membrane receptor repertoir. J. Biol. Chem. 2005, 280, 6028-6035.
60. (b) Kenis, B.; van Genderen, H.; Deckers, N. M.; Lux, P. A. G.; Hofstra, L.; Narula, J.; Reutelingsperger, C. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp. Cell Res. 2006, 312, 719-726.
61. Kenis, H.; van Genderen, H.; Bennaghmouch, A.; Rinia, H.; Frederik, P.; Narula, J.; Hofstra, L.; Reutelingsperger, C. Surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J. Biol. Chem. 2004, 279, 52623-52629.
62. Murillo, O.; Watanabe, S.; Nakano, A.; Gokel, G. W. Synthetic models for transmembrane channels: structural variations that alter cation flux. J. Am. Chem. Soc. 1995, 117, 7665-7669.
63. Leevy, W. M.; Gammon, S. T.; Jiang, H.; Johnson, J. R.; Maxwell, D. J.; Marquez, M.; Piwnica-Worms, D.; Smith, B. D. Optical imaging of bacterial infection in living mice using a fluorescent near-infrared molecular probe. J. Am. Chem. Soc. 2006, 128, 16476-16477.